2.77 (-%)
As of Dec 03, 2024
Source:
Relmada Therapeutics, Inc. is a clinical-stage, publicly traded biotechnology company developing NCEs that potentially address areas of high unmet medical need in the treatment of depression and other CNS diseases.
Country | United States |
Headquarters | coral gables, florida |
Phone Number | (786) 629 1376 |
Industry | manufacturing |
CEO | Sergio Traversa |
Website | www.relmada.com |